/PRNewswire/ The "Malted Barley Market by Application and Geography - Forecast and Analysis 2022-2026" report has been added to Technavio s offering. The.
Microbix & SpeeDx Form Exclusive Collaboration
Search jobs
MISSISSAUGA, CANADA and EVELEIGH, AUSTRALIA
April 26, 2021 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, and SpeeDx Pty. Ltd. (SpeedDx), a developer of innovative molecular diagnostics solutions, are pleased to announce the formation of a collaboration under which Microbix will be exclusive developer of Quality Assessment Products (QAPs™) to facilitate the registration and commercialization of SpeeDx diagnostic assays.
The collaboration will begin with support of SpeeDx’s diagnostic tests for infection with antimicrobial-resistant (AMR) strains of
Mycoplasma genitalium (AMR MGEN), a widespread sexually-transmitted infection and a test market expected to exceed US$ 1.0B globally by 2027. AMR MGEN is known to have multiple mutations that render certain antibiotics ineffective against it. Accurate diagnosis of such drug-resistant infections requires c
Share:
MISSISSAUGA, Ontario and TORONTO, March 15, 2021 (GLOBE NEWSWIRE) Microbix Biosystems Inc. (TSX:MBX, OTCQB:MBXBF, Microbix®)), a life sciences innovator and exporter, and Seegene Canada Inc. (Seegene®), a provider of leading-edge molecular diagnostics assays and instruments (made by Seegene Inc. of Seoul, Korea), are pleased to announce a collaboration under which Seegene will distribute and recommend Microbix s new COVID-variant Quality Assessment Products (QAPs™) to monitor the workflow accuracy of Seegene Allplex® assays across Canada.
In this collaboration, Seegene becomes a QAPs distributor and will recommend Microbix s whole-genome COVID-variant QAPs to support Seegene s molecular assays that detect the more-contagious emerging strains of the SARS-CoV-2 virus – initially the Brazilian, South African, & UK variants (P.1, B.1.351, & B1.1.7 respectively). Seegene s unique Allplex assays more rapidly and economically detect the genetic point-mutations associated